Research Papers

25 of 25125 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Tolerance and efficacy of preoperative intracavitary HDR brachytherapy in IB and IIA cervical cancer.
Bialas B; Kellas-Sleczka S; Fijalkowski M; Raczek-Zwierzycka K.
J Contemp Brachytherapy (Unknown)
Published: 2009
Comparison of two techniques of interstitial pulsed dose rate boost brachytherapy in conservative treatment of breast c…
Serkies K; Tarnawska Z; Blukis A; Badzio A; Jaskiewicz J; Jassem J.
Unknown Journal
Published: 2009
1/6 Transparent
Funding Declared
HDR brachytherapy (HDR-BT) combined with stent placement in palliative treatment of esophageal cancer.
Kanikowski M; Skowronek J; Kubaszewska M; Chichel A; Piotrowski T.
J Contemp Brachytherapy (Unknown)
Published: 2009
Combined therapy: surgery and intraoperative HDR brachytherapy for locally advanced and recurrent rectal cancer. Practi…
Gierej P; Radziszewski J; Lyczek J; Kawczynska M; Kulik A.
J Contemp Brachytherapy (Unknown)
Published: 2009
Correlation between treatment plan parameters and particular prognostic factors in prostate cancer treated with high-do…
Chicheł A; Kanikowski M; Skowronek J; Dymnicka M; Piotrowski T.
Unknown Journal
Published: 2009
Boost in radiotherapy: external beam sunset, brachytherapy sunrise.
Maciejewski B.
J Contemp Brachytherapy (Unknown)
Published: 2009
Brachytherapy in breast cancer.
Fijuth J.
J Contemp Brachytherapy (Unknown)
Published: 2009
Hyperfractionation of HDR brachytherapy - influence on doses and biologically equivalent doses in clinical target volum…
Skowronek J; Zwierzchowski G; Piotrowski T.
J Contemp Brachytherapy (Unknown)
Published: 2009
HDR brachytherapy as a solution in recurrences of locally advanced prostate cancer.
Łyczek J; Kawczyńska MM; Garmol D; Kasprowicz A; Kulik A; Dąbkowski M; Czyżew B; Gruszczyńska E; Bijok M; Kowalik Ł.
J Contemp Brachytherapy (Unknown)
Published: 2009
Trans-hepatic technique and intraluminal Pulsed Dose Rate (PDR-BT) brachytherapy in treatment of locally advanced bile …
Skowronek J; Sowier A; Skrzywanek P.
J Contemp Brachytherapy (Unknown)
Published: 2009
PSA bouncing after brachytherapy HDR and external beam radiation therapy: a study of 121 patients with minimum 5-years …
Makarewicz R; Lebioda A; Terlikiewicz J; Biedka M; Wiśniewski T.
J Contemp Brachytherapy (Unknown)
Published: 2009
Interstitial brachytherapy guided intensity modulated radiation therapy (IBGIMRT) in cervical cancer: a dosimetric stud…
Sharma DN; Subramani V; Rath GK; Jothybasu KS; Bahl A; Julka PK; Gopishankar N.
J Contemp Brachytherapy (Unknown)
Published: 2009
Cosmetic effect in patients with early breast cancer treated with breast conserving therapy (BCT) and with HDR brachyth…
Kulik A; Łyczek J; Kawczyn Ska M; Gruszczyn Ska E.
Unknown Journal
Published: 2009
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets.
Cardoso S; Santos R; Correia S; Carvalho C; Zhu X; Lee HG; Casadesus G; Smith MA; Perry G; Moreira PI.
Pharmaceuticals (Basel) (Unknown)
Published: 2009
Real Time Imaging of Biomarkers in the Parkinson's Brain Using Mini-Implantable Biosensors. II. Pharmaceutical Therapy …
Broderick PA; Kolodny EH.
Unknown Journal
Published: 2009
1/6 Transparent
Funding Declared
Malaria-Infected Mice Are Cured by a Single Low Dose of a New Silylamide Trioxane Plus Mefloquine.
Woodard LE; Mott BT; Singhal V; Kumar N; Shapiro TA; Posner GH.
Pharmaceuticals (Basel) (Unknown)
Published: 2009
1/6 Transparent
Funding Declared
The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular…
Imig JD; Carpenter MA; Shaw S.
Pharmaceuticals (Basel) (Unknown)
Published: 2009
1/6 Transparent
Funding Declared
Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon.
Friedman RM; Contente S.
Pharmaceuticals (Basel) (Unknown)
Published: 2009
Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases.
Camins A; Junyent F; Verdaguer E; Beas-Zarate C; Rojas-Mayorquín AE; Ortuño-Sahagún D; Pallàs M.
Pharmaceuticals (Basel) (Unknown)
Published: 2009
1/6 Transparent
Funding Declared
Effect of Different Metal Ions on the Biological Properties of Cefadroxil.
Auda SH; Knütter I; Bretschneider B; Brandsch M; Mrestani Y; Große C; Neubert RH.
Pharmaceuticals (Basel) (Unknown)
Published: 2009
1/6 Transparent
Funding Declared
Oxytocin: Old Hormone, New Drug.
Gutkowska J; Jankowski M.
Pharmaceuticals (Basel) (Unknown)
Published: 2009
1/6 Transparent
Funding Declared
Coenzyme Q10 and Neurological Diseases.
Mancuso M; Orsucci D; Calsolaro V; Choub A; Siciliano G.
Pharmaceuticals (Basel) (Unknown)
Published: 2009
Combination Therapy with Olmesartan and Amlodipine in the Treatment of Hypertension.
Niemeijer MG; Cleophas TJ.
Pharmaceuticals (Basel) (Unknown)
Published: 2009
Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-In…
Novo S; Fazio G; Raccuglia E.
Unknown Journal
Published: 2009
Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene.
Stafforini DM.
Pharmaceuticals (Basel) (Unknown)
Published: 2009
1/6 Transparent
Funding Declared